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ABSTRACT

Indirect evidence (Blaber. 1963) has .uouted that facUttatoIT
drug. mal' potenUa,. the mUlcte twitch and anta,oni.e tubocurariae without
lDbibttln, aceVlcholilleatera•• (AChE). 1ft the pre••nt

.tuq th. bldir.ct17

sUmulated cat anterior tibla11. mu.ct. wu -eel; dr'up w .... lajeeted clo.e

arteriaUy (5 microlftml. aad iIltraveD~ (JIO microFilm.). At the

het.t of the facilltatol7 effect. DW was irQecteci intravellCJ\laq ill doa..
wbich completel, iDblbited ACbB tn c_trot . .erimeng. The femoral
artel')' and vela were ••aeqaentl7ltpted. Oae hour later, the mu.cle

wu removed ud .tafAed for ACd Uln, the ltoeU. teelmique. The pre·
...ce of .talA indicated. AChE protecUcm b7 the faeWtato17 drup and

enqme iDhtD1U.n at facUitato..,. do.... Aulo.,.. In !U£! .tudie. w.re
performed. Small . . . . of ",.Ufmble and edNphooS.vm, given clo.e
arteriaUy, and larger d•••• of edrftphoJW.lm, "va lntrav8IlOWI17.

facilitated neurom'Ucu1ar traAami.8101l without iIlbtblUn, ACbB.
Ambenold.um, atvan clos8 arteriaUy, and ambenoalurn and ne08tig.mine,

given 1ntrav••...q. 1Dh1blted AChE. Methoapmbenonium produced
aUght lDhlblti_ "vea m:traveJlGWl17.r cloee uterla1l,.. Alternate

tbeorle. to the anUeho1lne.tera.e the.17 of the meeh.ani.m ., acUon of
the.e compoundl are discused.
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INTRODUCTION
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t.

ANATOMY AND PHYSIOLOGY

'lbe mechan1am of actton of facUitatory drugs at the neuromuscular
junction is not yet agreed upon. Disagreement exists as to whether or not
the drugs in question inhiblt chOlinesterase. The drug •• neoatigmine.
edrophonium, ambenontum and methOXl'ambenonlum are reveraible inhibitors
of acetylcholinesterase and the degree of 1nh1biUon in vivo produced by a

facilitatory dose Is contrcwersi&!. The experimelt" described in this thesis
were performed with the objective of obtaining more information on this
point. A short account of the anatolDJ and plv'slo10l1 of the neuromuscular
junction precedes a review of the present state of the problem.
A. Junctional Mo;rpholOfl
a. Gross
The motor nerve to the anterior tibialis musele consists of ft.bers
1-20 microns in dlameter. An impulse travels in this type of fiber at a speed
of 5... 120 meters per second with a spike duration, including the absolute and
relative refractory periods in the order of 0.4... 0. Ii milliseconds. The nega ..
tive after potential ran,.s from 12 to 20 mUltseconds and represents

a-5" of

the spike height. The positive after potential ts 40... 80 mUlisecouds in duration and represents approximately O. 2" of the spike height (Gasser, 1941).
The nerve divides approximately seven times and innervates in the order of
120 muscle fibers comprising a motor unit (Sherrtngton. 1925; Clark, 1931).
The units are not compact but are spread throughout the entire muscle. In

3

most mammalian muscles there is a OI1e to one ratio between nerve branches
and m.uscle fibers; that 1s, each muscle fiber is innervated by only one nerve
branch .. The tibialis anterior muscle of the eat has been used for the experi..
ments discussed in this thesis and consists of such focally innervated muscle
fibers. At the terminal the axon loses. its myl1nated sheath (Wagner, 1847).
Hubbard and Schmidt (1961) have shown that in the motor nerve terminal the
time course of the action potential!. 1.3 ... 3 millb&econds, the negative after
potenttalis 15-30mUllseconds, and tile positive after potential is 50 milliseconds. These resemble closely the properties of the main axon.
b.

Ultrastructure
The study of the fine structure of the

IB uromuscular

junction Is of

considerable interest for onlJ in the last decade has it been possible, with
the use of the electron microscope, to find new elements of structure which
begin to provide a morphological basts for the newer understanding of junctional functiGn.

The dIagram (fig. 1) illustrates the more important anatomical
features ef the neuromuscular junction .s stUdied with the aid of the electron
microscope. Each of the nerve fibers terminates or lies in a synaptic gutter
of the muscle which is made up of ••eries of foldings called "junctiOl1&I
folds" (Couteaux, 1944). The receptGrs for the transmitter as well as the
enzyme necessary for transmitter destruction are believed to be located in
the junctional folds (Koelle and Friedenwald, 1949; Waaer, 1959).

4

FIGURE 1

Schematic drawing of a neuronluscular junction as seen with the aid of the
electron microscope.
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Synaptic v.sicl.s aN found in the prejunctional or DOnie end.,s.
These are hollow spherical elements of abeut 100 A0 in diameter and by
chemical methods it can be shown that the transmitter acetylcholine and the

choline-acetylase system for the production of acetylehollq are concentrated
In the subfraction eoniaininl the synaptic veslcias (De RObertis, Pellegrino
de lraldl, ROdriguez de Lore. Arnaiz, and 8alpnlcoff, 1961; De RObertis,

Rodrlgu•• de Lo..s Aruaia, SalgaDlcoffi PeUegrino de lr81d1, aDd Zieher,

1983). The vesicles are pOstulated to

now towardtbe axome terminal mem-

brane and dischar,e tileell.wcal medtator lilt. the tntermembranale1eft.

The nerve terminals and ·mu8cl. fibers are .eparated· by continuous
membranes (Couteaux, leaO). The•• m.embranes show specia.11zatlGn

COn-

.ist.... Of patch•• of hi,h e1eetren denslv ea11ed "active petnts" (Couteaux,

1961). The jUnctional c'-It between the oppHlnr membrane. at these pelats
18 up to 600 A0 wide CAnder8son-Ctder,ren, 1959,. The postsynapUc mem-

brane Is depressed at replar i.iltervals into told8 that run at right angle. to
the fiheraxis and communicate with the extemal space at both 81des of the

nerve terminals. These junctional folds were named the" subneural
apparatus" by Couteaux (1947). These tolds aN ••rta.lnq a device fOr

inereasin, cOllSlderabl¥ the surface of the subaynapUe membrane. 'I'hia
increa.e bas been caloulated to·be ot abOut 4... 6 times (Andersson-CederIND,
1859). 111 the tro" the lonritudinal spaoing of the folds is rather rep1ar aad
it has been emphasised that the contacUng portieu of the~.tsynaptio

membrane stain more heavily (Birks, Huxley, and Katz, 1960).

They

postulate that a special protein layer may be attached to large parts of this
membrane.

It would be tempting to identify this postsynaptic density as the

locus of chemoreceptive function, but without further proof its role remains
obscure.
Koelle and Friedenwald (1949) first showed histochemically the
existence of a high cholinesterase activity at the level of the motor end-plate.
The exact localization was, however, obscured by diffusion artifacts.
Couteaux and Taxi (1952) obta.iued a more accurate localization by slight
changes in the echnical procedure and found that the structures stained by
the acetylthiocholine method are identical with the subneural apparatus
previously identified with supravital methods.

They concluded that the

subsynaptic membrane contributes the major portion of the total cholinesterase activity.

However, recent histochemical studies using electron

micrographs have shown some cholinesterase to be present presynaptically
in the membrane and vesicles (Barrnett, 1962).
Interesting studies have been carried out on the neuromuscular
junction with the use of radioactive drugs that will bind specifically the
receptors normally occupied by the transmitter.

Waser (1959), using

radioactive curarine, has calculated tha.t one end-plate contains about 107
receptors which would occupy only about 2% of the highly folded subsynaptic
membrane.

These receptors might be localized at certain points of this

membrane and not dispersed throughout it.

B.

7

Junctional Transmission
a. Acetylcholine

It is now generally accepted that acetylcholine is responsible for the

transmission of the excitation from the nerve endings to the motor end-plate.
Brown. Dale and Feldberg (1936) discovered that acetylcholine was involved
in transmission at the neuromuscular junction by identifying it in the perfu-

sion fluid after stimulating the nerve to the hind limb muscles of the cat.
Injection of acetylcholine into arteries supplying the gastrocnemius muscle
caused a quick contraction of the muscle.

It has been confirmed that

stimulation of motor nerves in isolated muscle preparations causes the
release of acetylcholine (Straughan. 1960). Microelectrode techniques have
shown the quantity of acetylcholine necessary to produce a response is 1. 5 X
10- 15 gm.

(Krnjevi~ and MUedi. 1958). which because of the narrow gap at

the junction is a concentration of approximately 1 X 10- 3 M.
Cholinergic fibers contain an enzyme. choline acetylase. which in th
presence of adenosinetriphosphate forms acetylcholine by transferring
acetate from acetyl coenzyme A to choline (Nachmanson and Machado. 1943).
There is more than enough choline in the olasma to support this synthesis
no matter how heavy the traffic of nerve impulses. Choline being a
quaternary compound is unable to penetrate nerve axons by passive diffusion
so the nerve endings must extract the choline from the extracellular fluid.
Birks and MacIntosh (1961) have postulated a choline carrier in the terminal
axonal membrane.

The release of the transmitter accelerates its formation

but the mechanism of this is not understood.

Choline acetylase is found all

along the nerve trunk. Acetylcholine and choline acetylase are stored in the
synaptic vesicles (De Robertis and Bennett, 1955). Even In the absence of
nerve impulses there is a spontaneous rel.se of acetylehollne from the nerve
endings giving rise to minute voltage fluctuations in the region of the motor
end-plates; miniature end-plate potentials, about 1% of a full end-plate

potential (Fatt and Katz, 1962). On the arrival 01 a nerve impulse there is a
simultaneous release of a large number of quanta of acetylcholine. This is
caused by a depolarization of the terminal causing an influx of caleium which
alters the properties of the vesicle. Or the axoplasm just inside the membrant

so that the vesieles spill their contents into the synaptic gap (Birks and

MacIntosh, 1957). Depletion of calcium reduces the output of acetylchoUae
and the frequency of minlature discharge. Magnesium lons have;,the opposlte
effect; an increase in magnesium ion concentration deereases acetylchOline

output (Del Castillo and Engbaek, 1954; Hubbard, 1961).
The combination of acetylcholine with its receptOrs makes the end ...

plate permeable to aU free anions and cations on either side of the membrane
so that the local potential in this region tends toward an equUibrium level.
This localized end-plate negativity is known as the end-plate potential. When
the end-plate petent1al reaches a threshold level (about 1/2 resting value in
the frog (Naatuk, 1955) or 1/4 resting value in the cat (Boyd and Martin,
1956) ) the membrane ls short circuited and surrGWldlng areas of the mullele

membrane,. still in the resting state, discharge into this current sink and a
muscle action potlilntial is initiated and propagates away from the. end-plate
region (Eccles, Kate, Kuffler, 1941). The amount of acetylcholine released
is in exclilss of what is needed to reach threshold (Brown, 1937), and yet it
disappears quiclt.q allowing the end"'pla.te to repolarize before b

end of the

refractory period of the muscle fiber.
Cholinesterase is responsible in part for the rapid disappearance of
acetylchOline but L'le end-plate potential is still short... lasttng in the presence
of choUnesterase inhibitors {Eccles, Katz, Kutner, Ui42'.

Other mechan-

isms for the rapid removal of acetylcholine, such as rapid diffusion to
sUDthreshold concentration (O,ston, 1955) or resynthesiS to a chemical
precurSQr (Abdon. and Bjarke, 1945) have been suggested. The presence of
cholinesterase may be merely an em.ergency mechanism tor the removal of
abnormally excessive amounts of acetylcholine. However, the artificial
conditions of some animal experiments ma.y be what cause it to appear
wmeeessary. (Blaber, 1962).
b.

Cholinesterase
The cholineaterases constitute a group of esterases which hydrolyze

choline esters at a higher rate than other esters. All esterases which show
this specificity are inhibited 1>1 10- 5 of eserine (Richter and Croft, 1942)
and are much more sensitive to quaternat"'1 ammonium ions than are other
esterases. This outstanding affinity of cholmesterases for cationic

1 ,-<:

substrates and inhibitors is the moat characteristic feature of the.e ensyme.,
and suggests that the active center of choUnesterases, in contrast to other
esterases, include. a negative group (nanionic stte n ) in addition to the esterbinding group ("esteratic site") (WUson and Bergmann, 1950).
The exiatence of an enqme responaible for the destruction of the
humoral transmitter was suspected by Loewi (1921) early in his studies of
the nvapsatoff" and later demonstrated by Loewt and NavratU (U'2G). Later
studi•• showed that those portions of skeletal musele that had a high concentration of motor end-plates also contained the most acetylcholinesterase
(Couteaux aDd Naehmansohn, 1940). The classic investigation by Marnay and
Naehmanaohn (Ul37) demonstrated that there was enoup acetylcbolinesterase
in the end-plate region of the frog to hydrolyze, during the few mUliseeonds

of the refractory period, the amount of acetylcll.line calculated to be

released from the nerve termtnal. Sim11ar studtesled t. the same cone1uslons tor tbe toad (Feng and Ting, 1938). Nerve degeneration

e~r1ments

led to the conclusion. that wbereas there was some acetylcbolinesterase
activity in tbe terminal nerve branches, most of the enzyme activity was
localised in the subneural region (Sawyers, Davenport, Alexander, 1950;
Brooks and Myers, 1952). Refined microchem.leal1nvestlgations bave
confirmed earlier conclusions that acetylcholinesterase is intimately
assoc1ated with motor end-plates (Couteaux and Nachman.ohn, 1940).

.1 )

Considerable work. has been devoted to the localization of cholinesterase in muscles. When oure histochemical techniques are applied to
normal muscle, cholinesterase is found at the following sites as summed up
by Beckett and Bourne (1957).

1. Small classical end-plates arranged in straight rows across riluscle fiber
or in groups. The cholinesteras. in the end-plates is of two kinds, predomlnantly acetylcholinesterale but also butyrocholinesterase (Denz, 1953;
Holmstedt, 1957). Most of the acetylcholinesterase at the junction is postsynaptic and belongs to the

150- called

subneural apparatus. Very little ia

presynaptic (Zacks, 1964).
2. Plates composed of i)8raUel gutters arranged .s a "cake CrUI" or

palisade, the gutters being oriented in the Sanle direetion as the long ald.s of
the muscle fiber (Couteaux and Taxi. 1952).

8. Large cap-shaped areas situated over the ends of ,r1'1usc1. fibers, with
gutters arranged in paranel or in a somewhat reticular :)attern. These

endings are .. in fact, situated at the rnu8culo-tendinous junctions (Gerebbolt,
1959). They are also found where muscle tibers end in the middle of a
bundle.

The pos.1b1lity exists that these I.uay not be n. otor end- plates but

su-etch receptors"·lf this 18 so, then the :lr.sence in them ot acetylchol1n...
esterase 1s of
4.

80me

interest.

Cholinesterase is also present in muscle spindles.

bOth

in the end-plates

of the intratusal fibers and in the fibers theInselves (Coers and v" ooU" 1959).
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Gerebtzoff (t959. has shown that ,the speed with which a m.usele

contracts Is dependent more u.pon acetylahoUne sensitivity than upon the
am.ount of eholin.st.rase preHnt.
KaeU.'and c..-...oJ"ker•.haft lnd1cated that the totalneu.roaal

aee\ylohe11nesteraH eorudet.of a nftmetlonalIt portion extemal to a '
relatively lm.p4lrrneab1e, .eUular Ddtmbrane and an internal port1_~ It has

been suggested that the internal or "reserv." portion represents the souree
for the replacement of the fwtottonalenzyme .1 the _en surface and' could
pOlsf.bq belden.tlealwlth the endoplallmte Ntteu1um. Ql'ukuda and KGel1••

lt59'.

n.

PHARMACOLOGY

Numerous compounds capable of facilitating neuromuscular trans ..
mission. have been synthesized. Many of these have been shown to possess
anticholinesterase activity and it was natural to ascribe the effects of these
compounds on skeletal muscle to inhibition of the enzyme at the neuromuscular junction with the con.sequent preservation of the transmitter. In recent
years the lack of correlation between the ability of certain of these compounds
(See Fig. 2) to facilitate neuromuscular transmission and to inhibit cholinesteraee in vitro has led to research which shows that some of these compounds
cause at least a part of their facilitating action via other mechanisms
(Randall. 1950; Wesco. and Riker, 1951; Riker. 1953; Karczmar. 1957;
Blaber, 1960; Blaber and Bowman. 1962; Blaber. 1983).
A. NeostiJD?!!e
Neostigmtne is a synthetiC anticholinesterase which was developed as
an outcome of the studies of the chOlinesterase-inhibiting properties of
physostigmine. Although there is 11ttle difference between the.!!!.!!!!:9
potenCies of neostigmine and physostigmine to inhibit cholinesterase in
various speCies (Nachmansohn, Rotherberg and Feld. 1948), the anticurare
and twitch potentiating action of the former drug is much more rapid in
onset than that of the latter (Riker and Wellcoe. 1946). The rapidity of action
of neostigmine compared to that of physostigmine can probably be ascribed
Simply to a more rapid rate of combination with the receptors (Blaber, 1982).

1l

FIGURE 2
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In the rat diaphragm. neosUgmine antagonizes not only the neuro"

muscular paralysis by curare but also par~sis by depolarizing blockers
such as decamethonium (Seeher, 1951). Tht. antagonism of depolarizing

blockade does not bold true blthe cat though, for an increase of the blocka,.
is observed (Bowman, 1962). Neosttgn'rlne Is

knOW]l.

to have a direct aetlon

at the neuromuscular junction in additiOn to its anticholinesterase actiOn
(Riker and

Wes~CIe.

1946), but this has been shown to be too weak to contri-

bute to U. action at the neuromus9ular junction (Slll1th. Cohen, Pelikan, and
Un$l, 1962; Hobbtger, 19&2; Blaber, 1962). Berman-Retsberi(1957)

showed

u..t neoattgmfnetnhlbtted Choline-acetylase but 8X 10-1 M waa

neeessary to eause 5010 tnhlb1t1on wb.lch is strlld.ngJ.y difterent from the
potency to 1nhlbit ace'Vlcholinesterase•. 50" tnlUbttton bein, p1"Qduoed b:;
2.8 X 10-'1 M, 1. e. at a concentration Of approxtmately 40,000 time. les8.

'111. finding that drugtl of tIlts type pOtentiate the aetlan of applied acetyl-

choline is me"ly a demonstrattOl'1 that in sufficient concentration they
posse•• an ant1cbol1nesteras. actiOn. The question of whether this is the

801., Or even the main mechanism of action of these compounds in the
lUIual effective do.ses i8 not answered.

B.

EdrophQft1l!tn

'l"he compOUnd ed1"Ophonlum 18 a particularl, tnterestingsubstance

beeaus. It reveal. some of the weakness•• in the experimental methods. It
18 a quaternary compound whleh 1Bhf.blts the enfl7me reversibly by eomb1nJ.l1ft

,16
with it onl\Y at the anionic site, and thus blocks attachment of the substrate

(Holmatedt, 1959).
The rapid on.set and short duration of action of edrophoniurn with
respect to neostig::.n1ne has been noted by a number of blvesUgators (Cowan,
1988; Macf arl.a.ne, Pelikan and Unna, 1950, Riker, 1953; \VUSOll, 1955).

The

ability of this COlA.'lpound to reverse the nellromuscu!ar blocking aotion of
tubocurarine is well kno\\n also, but t...... e earliest experiments indicated that
it was only a feeble

allticholinest~n'3.se,

about one-hundredth aa potent as

neostigmine (Randall.. 1950; Hobbiger, 1952). It was of interest to compare
the time course of action and potency ot this compound ...........
in vitro and in vivo,

----

---~

since it had been presumed that the anticurare and acetylcholine potentiating
properties of edrophoniuIU and neostigmille are primarily the result
anticholinesterase activity.

at their

Smith, Cohen, Pelikan, and Unna (1952)

obtained results which indicated thatedrophon1urll was as luuch as Qne-quartel' as active as neostigmine. These same workers found that there was no
positive correlation between the relative potenCies of the compOund as an
anticholinesterase and its abU1ty as potentiator of acetylcholine on the
frog rectus muscle. The 'inhibition of cholinesterase byedrophonium was
reversed by the addition of substrate too rapidly for the time course to be .
measured with the manomeu'ie teehn1que. The evidence obtained neither
directly confirmed nor negated the thesis that the potentiation of acetylchoUne and antagonism of tubocurarine produced by this compound is the
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result of its inhibition of cholinesterase (Smith, Mea.d, and Unna, 1957).
¥/nson showed (1955) that for the acetylcholinesterase of eleetrlc eel
at 20° C, Ki for edrophonium
neosttgmin.e.

Th~

W1UJ

3 X 10... 7 as opposed to 10. 7 for

rate of fo!'mation (and of dissociation) for the complex

'with edrophonium, was much greater than that for neostigmine.

Contrary

to observations 'With neo:!tlgmine, potentiation of l."esponse toacetyleboline
is ma.ximal a.fter an e:!.::posure to edrophonium for only two minutEts or les8
and decreases subsequently over a period oi 10 to 20 minutes untn it

rea.ches an equilibrium value. The formation of the enzym.e·inhibitor
complex in the absence of substrate is completed in IS seconds.

The

reverse reaetion proceeds rapidly also (one-half dissociation \vas not more
than 30 seconds). The one-half Ume dissociation tor neostigmine 1s about
12 minutes (WUson, 1955). If the experiments were performed in equilibrium conditions this should not affect the results, but if the ass()(:iation and
dissoelation of neostigmine does not have time to reach equtlibrium, it may
appear very much more powerful than edrophonium; in these circumstances
it is, in fact, behaving as a non-competitive "irreversible It inhibitor

(Wilson, 1955).

c.

Oxamides
Ambenonium ehlorlde(Mytelase: WIN 8077) and methoxyambenon1um

chloride (WIN 8078) are members of a series of btsquaternary oxamides
synthesIzed in the Sterling-Winthrop laboratories and first reported by

Arnold, Soria and Kirchner (1954).

Both are fl7MtrglaUc with neoet1arnme in

mice and both lacUitate traa8miaaiOl1 aDd oppose blockade ill the a~d3
nel'"YOWl .yatem (Karcamar and Howard, 1965).

Both eompounda.have bee.

shown to be rever.iDle 1nbiDltora of aeevlcho1taesterue (Karcamar and
Howard, 1965: Koelle, 1957; Bla.er, 1960). hl tb1a regard it wu fOWld fAat

ambenontum 111 more than 100 time. as active u metboqambenonium.
AmbenoDium diaaoc1atiOll occurs extremeJ7 81ow17 exceptiAgin the p.... ence

of relatively hiab coaeentraU. . 01 certalncaUou (KoeUe, 195'). Amlte. .-

atwn potent1a.te. the respe... to th. indirect af.ngle shock stimulation of cat

mud. ancl aataaonla_ curare blockade. AlthOllgh a powerful &aU-curare
agem. me.UJambeaOD1um does not potentiate the maximal twitch wl1IIlon
(Landa and Karczmar, 1951: Blaber, 1910). Ambenonlum wlU e11cit twitch

r ..pou•• on cl08e al1er1al1ajeeUoa aw.l aUg:tlle¥lt the excitatory aDd

paraqz1n. acUoa of acetylehoUne, succiD.ylcbOUUa and decametAon11am. on the
eatf • UbialU Inuada. Karczmar (1967) showed that methoqambenoa1um

produced re.eraal of the aeU_ of 8ucc1n71chollne... decamethonium on tne

eat'. tibl.aU8 muae1e. Alao, since methoqam,beDoldum aatagon1s •• pal'aqala
by curare and depctlarbinl

a,_tat as well, Kuczmar streBs.d 10

his diacu-

aloa that the curreut theone. on the mode of acUon of the depo1arizer.
offered an 1Daclequate explaaaUon tor the properU.s of metboqambenoDtum.
Blabe.. (980).flBdlag tbat both ambenODium

uo methoqambenoldUID

....lOniz.d the paralJ'.'a of curare and depctlarbera, arrived at the conclu-

al_ that larger dOM. thaD those required to aata,ontae curare are needed
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to

remre transmis.lon from. paral7.t. by deoaxnethom.um.

fOlmCl at th••e

htah... d. . ., oxamide. produced a

reaem.bliDI iD m&rI7

_,.8

Blabqt al..

neuromuscular block

that cauaed by eura.... AccordiDl11, he ......ted

that the anta,OId.sm of depolaris.rs was due to the cUr&NmlmeUc properti••
of the o.mkle••
The comp1exlv of • • detat1ed meehaa1.m of actloD. of . . .mide. ,.

apparent; there 1. DO correlatton between the ..elative ,..acy of the......nt.

curare ta that it ... antapnlNcl by tetanic .UmulatlOll aad upe1aristng ..,ent.,
It ... unlike that produced by curare 1D. that it 1. not antapaised by neoau,m!ae or eclrophomum (Blaber, ·1...).
D.

-DFP
AaUchoU.nestera..s. neb . . uoattp1.iD.e and edrophODium.. InIdbit

the ftl.7m.e

"reveratbl1"

by .om.b1DID, with It an.d

substrate. Caretw. ldaeUc studt•• have """e

bloekJat attachirlent of the

.own

that

oaq De,u,tble

amouate of aD. iDhiblto.. of this .,.,. are ...l....eeI ......eraib17 from the e..,me,
1D.cleecl, ueoatt,mJu ... tv'dro17s" eztrem.elJ

Ill". b.Y chollne8tera..

(W1la0ll, 18SI).

effect 81nU1ar to th••• of ........... neh a ....rtne

0 ..

aeoau,rrua. are
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(Koster, 1946). With the isopropyl group on the enzyme virtually no hydrolysis occurs and the return of cholinesterase activity depends on the formation of a new enzyme (Wilson and Bergmann, 1950). Their action is often
described as "irreversible,

II

but this is slightly misleading. Augustinsson

and Nachmansohn (1949) observed that the inhibiti:.on of cholinesterases by
DFP was not competitive; the reaction can be regarded as being roughly
a non-competitive one.

This only implies. however, that the stability of

the enzyme-substrate comples is so great that it is unlikely to be broken
up

U1..!!.y£.

The affinities of the organophosphorus compounds for the active

center are not very different from those of the "reverSible" inhibitors,
such as eserine or neostigmine (Davison, 1955; Burgen and Hobbiger, 1951;
Hobbiger, 1954; TammeUn, 1958). It is apparent that the terms "reverSible"
and Hirreversible" as applied to these two types of anticholinesterases renec
only quantitative differences, and that both classes of drugs react with the
enzyme in essentially the same manner as does the natural substrate.
DFP (diisopropyl phosphorofiuoridate) was synthesized by McCombie
and Saunders in 1946' and is considered an "irreversible" anticholinesterase.
After DFP treatment recovery of blood and tissue cholinesterase depends
on alkyl radicals and new enzyme synthesis (Blaber and Creasey, 1960a, b;
Koenig and Koelle, 1961). Recovery of erythrocyte cholinesterase is
4.40/0 per day for the first 15 days and thereafter it is decreased tp
approximately 0.8% per day (Oberst and Christensen, 1956). Studies
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indicate that ;;0 to 80% of the total cholinesterase of nervous tissue or
effector organs must be inactivated before pharmacological action8 are
noted (Koelle and Gilman. 1946; Riker and Vi, escoe, 1949; Kamijo and Koelle,
1952). Cause of death in DFP poisoning is respiratory fallure and in this

regard 1t haa been shown that lmpe.inllent of neuromuscular transmission
Gee• • firat, with fallure of the central mechan1sm immediately following
(\\i right. 1954).

Koelle (1950, 1951, 1955. 1957) haa used DFP for the ];>urpoa. of

determining cholinesterase inhibition by so-called "reversible inhtbitors. "
Usin, cytological localization of the enzyme as a techn1que he baa shown that
the "reversible" compounds will protect the enzyme from attachment with

an "irreversible" compound such ..s

DFP.

If the reveralble compound

inhibits the enzyme. it protects against OFF and upon d11uUon the enzyme

can be local1zed. If the test compound does not inhibit cholinesterase it wW
not protect against DIfP and an irreversible inhibition 18 obtained and the

enzyme cannot be localized.. In short, if a compound does not protect the

enzyme against DFF it 18 not coutdered a Il reverslblell an'tic1lo11n.estera•••
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In. mSTOCHEMISTRY

lbere are two general approaches to the cytc.)logicallocal1zatien of
sites of drug action: 1) to demonstrate at the cellular level the distribution
of the active drug following its administration or 2) to demonstrate changes

in a specific group or compound with which the drug 1. known to act. Because

the compounds we are interested in are reported to have an anticholinesterase
action we shall choose the second approach.
As an example of the qtological approach to pharmacoloQ, the
anticholinesterase a,ents represent a particularly favorable class of drugs.
The primary mechanism of action. of these agents is the inhibition

or

inactivation of cholinesterase. The thiocholine method of Koelle, when
properly contrOlled, 1. bOth highly specific and extremely sensitive for the
localization of cholinesterases. The exact site of cholineate rase, in relation
to the structural elements of various tissues, had been a matter of uncertainty before Koelle's technique beeame available. AcetyltlUoeholine, used

as the substrate in this technique, was first liyntheslzed by Renshaw (1938)
who noted that its pharmacol.,ical actions were similar to those of acetylcholine but of briefer duration. It Is known that it is hydrolyzed at a more
rapid rate than acetylcholine by cholinesterases, because of the weaker
linkage of the

-c-s. . than the -C-O.. bond.

The present experiments will not

attempt to differentiate between the dUferent types of cholinesterases because
in the area that is under study, the neurom)"al junction, the amount of

~3

acetylcholinesterase represents approximately 950/0 of the cholinesterase
present in the area (Giaeoblnt and Holmstedt, 1980).
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IV.

PURPOSE

Blaber (1963), comparing the saIne drugs as used in the present work,
found that their abUity to potentiate the muscle contraction produced by at
close-arterial injection of' acetylcholine was clesely correlated with their
in vitro anticholinesterase potency.
-

However, there was no correlation

between J!! vitro anticholinesterase potency and their abiUty to potentiate
the muscle twitch elicited by the stimulation of the nerve, or with their

anti-curare activity. It was concluded that some action, in addition to
inhibItion of chollnesterase, contributed to their facilitation at the neuromuscular junction, and it was suggested that this action may be at the
prejunctional site.

The purpose of the present work is to

tl")'

and provide more direct

evidence on the ability of thea. compounds to inhibit cholinesterase at the
dose levels Blaber used by observing their effeet on muscle twitch, ,removin,
the muscle and staining for cholinesterase using the 1951 acetylthfocholine

method of Keelle.

MA TEBlALS AND METHODS
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I. IN VIVO PREPARATION

Forty-two adult cats were used in

th~se

experiments ranging in weight

from 2.0 to 3.5 kg. The animals were anesthetized with choloralose
(80 mg/kg) intra pe ritoneally , fastened to the operating table in a supine
position and the trachea cannUlated. A polyethylene cannula was placed in the
lett femoral artery and connected to a Stratham pressure transducer for the
purpose of recording blood pressure. To prevent clotting this cannula was
filled with heparin solution (200 units per mI.). Blood pressure was recorde
to provide an index of the animal's condition during the experiment.
A. Preparation For The Administration Of Drugs
The left femoral vein was cannulated for intravenous drug administration. The polyethylene cannula was connected to a three-way stopcock and
clamped to a support of the operating table. Since both left femoral vessels
were cannulated, the left anterior tibialis muscle received none of the drugs
administered and acted as a control muscle. In experiments requiring clOse
arterial injection of the test drugs, Blaber's (1960) modification of Brown's
(1938) method was used. The artery to the anterior tibialis muscle was
cannulated and the polyethylene cannula rUled with heparin solution (l00 units
per mi.), plugged untU ready for use and fastened to a support of the operating table. The right femoral artery and vein were exposed and a string
passed around the artery. For close arterial injections the femoral artery
was occluded as the drug was injected thereby assuring the drug did pass
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into the tibialis muscle. In all experiments tbe string was used to 11gate both
tbe femoral artery and vein shortly after all drugs had been administered.
B. Recording Of Mechanical ResP'!l;se
The right anterior tibialis muscle was exposed from mid-calf level to
its \ tendon insertion. The tendon was l1gatured and cut, from the bone of its t
insertion. The sciatic nerve on the right side was exposed and cut high in the
thigh. This was for the purpose of elimiDattng reflex responses during
muscle twitch recording. The nerve to the tibialis was then exposed on the
outer border of that muscle. Drills were inserted into the lower end of the
femur and the lower end of the fibula and tibia and the limb was rigidly
clamped in a horizontal position to the operating table. The ligature around
the tendon of the muscle was connected to a Grass Model 1fT-l0 force dis ...
placement transducer for the purpose of recording mechanical twitch. A
shielded platinum electrode was placed on the tibial nerve distal to the
severed sciatic nerve and connected to a Bioelectric Instrument isolator
which received pulses from a stimulator consisting ofa Textr<mtx Type 162
wavetorm generator and a Type 161 pulse generator. The cathode of the
electrode was placed nearest the muscle and a rectangular pulse Of 50 micro
seconds duration and twice the strength needed for maximal stimulation was
used at a frequency of once every 10 seconds. A temperature probe was
placed in the belly of the muscle and the muscle covered with a surgical
sponge mOistened with mineral oU. The muscle was maintained at 37°C

with heat lamps.
C. Experimelltal Procedure
The blood pressure, muscle twitch, and temperature were all monitored on an Offner Type R Dynograph. There was a 30 minute control period
of muscle twitches prior to the injection of drugs. After the control period a
reversible fac1l1tatory agent was given. The drugs were given either 250
micrograms intravenously or 5 micrograms (total dose) close-arterially.
All drugs injected, including DFP, were dissolved in O. 90/0 saline solution.
Saline was also used to wash intravenous injections into the felnoral venous
cannula. Close-arterial injections to the anterior tibialis were administered
retrogradely into the central end of the ligated tibial artery below the anterio
tibialis muscle. At the moment of injection the femoral artery was occluded.
The ligature around the femoral artery was released following the injection
of the drug and the cannula was washed through with heparin solution (100
O. 9%

units per ml. in NaCl). OFP was always given intravenously (15 mg/kg).
The OFP was dissolved in 0.90/0 saline in a concentration of 10 mg/ml and the
solution prepared within one hour of its injection. In the case of those drugs
which augmented the muscle twitch, the 15 'rag /kg dose of OFP was injected
at the point of greatest augmentation and if there was no increase in muscle
twitch the PFP was given intravenously 30 seconds after the reversible
facUitatory agent had been injected. At the peak of augmentation of the
muscle twitch caused by DFP the right femoral artery and vein were tied off
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and the stini ulue to the a.nterior tibialis stopped.

(This procedure was to

make certain the drugs were not com.pletely washed out of the muscle into
the Circulation).

The muscle was then m.aintained at 3S-3a o e for one hour.

After the one hour incubation period of the {Huscle in situ it was removed,
immediately placed in a glass container, covered and placed in the freezer
compartment of the refrigertor.

The animals which survived the organo-

phosphate toxicity were sacrificed by the irlJection of 30 cc of air into the
femoral vein.

The left anterior tibialis muscle was removed and frozen

in the same manner as the right muscle.
D. Histochemistry
a. Preparation of Sections
After the muscle was completely frozen a trapezoidal cross- section
of the distal one- half of the muscle was removed and placed on a microtome planchet.

A few drops of water were added to the planchet and the

planchet with the muscle on it was then placed into the freezing microtome
so that the muscle would become fixed to the planchet.

The muscle was

then sectioned in the microtome in 10-15 micron sections and placed on
glass slides which had previously been frozen in the microtom.e.

The sUdes

with the muscle sections on them were placed at room temperature until
thawing caused adherance of the m.uscle sections to the glass.
was 15 to 30 seconds.
solution.

This usually

They were then ready to be placed in the incubation
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b.

Staining Procedure
The histochemical approach for the determination of antichol1nester-

ase potency in the present study is based on Koster's (1946) observation that
a reversible inhibitor can prevent the lethal action of DFP by transient
competitive combination with the enzyme (Koelle, 1946). The technique
outlined below is Koelle's 1951 method. As developed originally (Koelle and
Friedenwald, 1949), it consists in incubating fresh frozen sections in a
medium containing acetylthiocholine and copper glyclnatej as the substrate is
hydrolyzed by acetylchOlinesterase the thiocholine liberated is preCipitated
as a mercaptide salt" e. g., copper thiocholine sulfate. The initial concentration of the substrate (acetylthioehoUne) of 5 X 10- 8 M, is the optimal
concentration of acetylcholine for specific cholinesterase (Augustinsson,
1949). Immersion in ammonium sulfide converts the white precipitate of

copper thiocholine to a dark brown preCipitate of copper sulfide 'Which can
then be viewed with an ordinary microscope.

~cetylthlochol1ne

ion

(NH4)2S

CuS

~(----------------

Thioeholine ion
(plus copper glycinate)
(CuSCH2CH2N( CHS)S)SO 4::'

Copper thiochoUne sulfate
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REAGENTS
1. Copper-Glycine:

3.75 gm.glycine, 2.50 gm. copper sulfate q. s.
100 mIs.

2. Maleate Butfer:

9. 80,m. sodium maleate, 52.2 mls. sodium
hydroxide, q. s. 100. 0 mls.

3. Sodium Sulfate:

40 per cent sodium sulfate (W IV), adjusted to

pH !. 00, stored at SSoC.

am.

4. MagnesiUm Chloride:

9. 52

5. AcetylthiochoUne:

mgm. acetylthiOChoUne iodide,
mls.
water, O. 8 ml. 0.1 M copper sulfate; centrifuged
supernatant decanted off and saved.

8. CopperthlochOline:

Obtained by filtering incubation solutions immediately after removal of sUdes, storing at SSoC.fo
two to four days to permit spontaneous hydrob"sis
of substrate, eollecUng preCipitate by centrifuption and washing with water.

7. Incubation Solution:

o. (I mi.

magnesium chloride, q. s. 100. 0 mIs.

'8

2.'

solution 1,

o. (I ml.

water, 1.5 mls.

solution 2, 10. 5 m1s. solution 3, O. 6 ml. solu-

tion 4, 1.2 mIs. solution 5, trace of solution 6.
8. Ammonium Sulfide:

25 mls. absolute alcohol, 4. 5 mIs. ammonium

hydroxide, 3 mls. water; saturated with hydro-

,en sulfide; tested for saturation with 1 drop
0.1 M copper sulfate; fUtered just prior to use.

All slides were marlted with a diamond pencU for identification and
placed in the incubation solution for a period of 20 minutes. Tbey were then
transferred to a rinse solution of 200/0 sodium sulfate for 6 minutes and then
immersed for 2 minutes in 10% sodium. sulfate. This was followed by dipping them in distilled water for SO seconds and transferring them to the
ammonium sulfide developing solution for a period of 2 minutes. They were
then stained and dehydrated by one minute rinses in alcohol and eosin,
alcohol, xylol, and another xylol solution. All the above solutions were
saturated with the reaction product by adding a trace of copperthiocholine.
The saturation of the substrate solution with the reaction product bas the
advantage tl:a t diffusion of reaction prod-Ilet is greatly diminished or suppressed. In order to minimize spontaneous

hydro~ sis

of the substrate

(ace'tylthiocholine) it was added immediately before the incubation solution
was to be employed. The solution was stirred and fUtered through Whatman
#J 1

filter paper into Coplin jars previously warmed in the incubator.
After the final xylol rinse the slides were mounted with Permount

(Fisher) and a cover slip. Slides were then viewed under a microscope at
SOX and photographed. All photOmicrographs were taken with the same

intensity of lighting, time of exposure, and not retouched.
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U. IN VITRO PREPARATION

Adult cats were anesthetized Intraperltonea1ly with choloralose
(80 mg/kg). The right anterior tibialis muscle was removed from the animal
and placed in a glass container. covered and frozen in the freezer compartment of a refrigerator. After the muscle was completely frozen. a trapezoidal cross-section of the distal one-halt of the muscle was removed and
placed on a microtome planchet. A few drops of water were added to the
planchet and both the planchet' and muscle were then placed in a freezing
microtome in order that the muscle would be fixed to the planchet. When
this had taken place ten... fifteen micron fresh frozen sections ·of the muscle
were cut on the microtome and placed on slides. As soon as the sections
had thawed and the excess moisture evaporated the slides were placed tor 5
minutes in a Coplin jar containing a solution of the follOwing composition:
24,. sodium sulfate. 0.033 M magnesium chloride. and one of the reversible

facUitatory drugs in a molar concentration calculated to be that which was
in the animal's extracellular fluid following its injection in the in vivo
preparation (assuming that a eat's extracellular fluid represents 15% of its
body weight). The reversible inhibitor was omitted from two sets of controls
All slides excepting one set of controls were then transferred to a solution
which contained the same components as above plus 10- 4 M DFP. The slides
were incubated in this solution for 30 minutes at 380 C. and then placed in a
rinse solution (24% sodium sulfate. 0.033 M magnesium chloride) in which
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they were kept for 30 minutes at room temperature. This latter step was
repeated. All slides (including the first set of controls) were then ready to
be placed in the Koelle incubation solution and to follow the same procedure

as the in vivo muscle slides.

RESULTS

;.;;sb

Before the rnain experbnents could be carried out it
find the

',\I

as necessary to

.m vivo concentration of DFP which vi/ould consistently inhibit cholin'"

esterue to such an extent that no staining of the enzyme could be demonstra-

--

ted. The in vitro concentraUons,vhich have been used in this method [or
inhibition of specl.flc eaterues range from 1 X 10- 1 M (Koelle. 1951) to
1 X 10.. 4 M (Koelle, 1957). We would expect the Ja.!!I2...concentratlon to be

similar.

Using increasing doses of D,F'P it \'.'a8 found that 15 mg/kg 1. v. was

the lowest dose of the organophosphate which would consistently InW.blt

stalaln, of cholinesterue (fig. 3). Assuming the extracenular auld to be
150/0 of the body weight the.!!l. vivo molar concentration of DFP in the extracellular nuid wu 1 X 10.. 4 M.

The hlstocher.nical approach to deternlination of the antichollnesteraae
actions of aInbenomuro, neostigmine, edrophoniUIll and rnethoxyarnbenonium
18 based on the observation that the reversible inhibitor, pbysostigmine, can
protect cats from the lethal action of the irreverSible anUchol1neaterue
agent OFP (Koster, 1946) by transient competitive combination with the
enzyme (Koelle, 1946: Koelle and Koelle, 1959). Therefore, the reversible

lDh1bltor was given immediately before a dose of DFP auff1clent, U given
alone. to cause practically complete inactivation of the acetylcholinesterase
al a given tissue.

Tbe excesa DFP and the reversible inhibitor was then sub-

aequenily removed; any residual acetylcholinesterase activity sbould represent that which was inhibited by the reversible inhibitor at the Urne the DFP
was glven.
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F IGURE 3

CONTROLS
In Vivo

NORMAL

DFP TREATED
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In the following results inhibition of muscle cholinesterase by OFP
is indicated by absence of staining in the photomicrographs and shows that
the test drug did not protect the enzy-tne from DFP and was therefore not
inhibiting cholinesterase at the time the OFP was injected. Staining of the
end- plates in the photo,raphs indicates that the test drug was protecting or
inhibiting the ellzy-me at the time the OFP was injected and reversed during
the staining procedure.

I.

A.

_

.

IN VIVO

Ne9lUgmine
The results with thls compound are shown in fig. 4.

The pbotonl1-

crographs show that at the close-arterial dose there 18 no staining of the
enzyme.

We can take this to mean that ne08tig;miDe did not inhibit the

enzym.e prior to DFP treatmeat so that the organophosphate gained access to

it. The photomicrograph of the intravenous dose allows atainlng

80

that

neostigmine was proteettng the enzyme from DFF in this situation. The
muscle twitch wu faeW:tated with both coacentrations of neostigmine to the

same extent and tba,t wu augmented further upon the addiUon of DFP. The
animals receiving the low dose of neoeUgmJ,ne died during the incubation
period with aU the signs of organophosphate poisoning.

The animals

receiving the htgher dose of neoatlgnline did not die after DFP althougb matty'
of the sips of pol.ODing were apparent.

B. Edroggsmium
The results of cho11nesteraee stalnlDg wUh this compound are shown

in fig. 5. Neither close-arterial or intravenous dose. protect apinst DFP.
The muscle tw1tell was tacWtated to the aame extent with both concentratl0D8
and was lurtber increased after adm1nistratlon of OFP.

AU animals died

during the incubationpenod In. viTO showlng insufficient protection of the
enzyme against DFP by edrophonlum.

The increase in twitch with both

eoncentrattOD8 of edrophonium before the DFP was adm1n1stered was in

F IGURE 4
NEOSTIGMINE IN

250 ug.

i . v.

5 ug. c. a.
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VI VQ~
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FIGURE 5
EDROPHONIUM IN VIVO

250 ug.

5 ug.

i. v.

c. a.

absence of any sign of fasciculations or other anticholinesterase intoxication
signs. This has been observed by other workers (Blaber and Bowman. 1959).

c.

Metho~ambenoni~

The staIning produced by this compound differed from the rest since
it was in such a small amount when it was observed. Since the Koelle meth
is mainly qualitative the results were planned to be either plus or minus
with little hope of any quantitation or Hpartial staining.

If

However. as shown

in fig. 6 there is definitely only partial staining. This appears as uniform
"hairlike" staining of acetylcholinesterase around the endplate. This type
of staining indicates that methoxyambenonium does not protect the enzyme as
well as neostigmine or ambenonium. The smaller dose of methoxyambenontum shows no protection at all against the action of DFP. This is in agreement with other workers who have found this compound to be a weak anti ..
cholinesterase (Karczmar and Howard. 1955; Koelle. 1957; Blaber. 1960).
It was also noted with this compound that there was an increase in muscle

twitch in four out of six experiments using the larger dose of the drug. which
is contrary to results of other worker.s (Karczmar, 1957. Blaber, 1960).
In one case with methoxyambenonium the animal died although partial
staining of acetylcholinef'tet"ale occurred.

The maximal twitch was not

potentiated in this case. In all cases the animals were in poor condition
during the in vivo incubation period of the muscle with all but one of the
animals dying of those given the low dose of methoxyambenonium.

FIGURE 6
METHOXYAMBENONIUM IN VIVO

250 ug.

1. v.

5 ug. c. a.

4 3..
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D. Ambenonium
Figure 7 shows that tbis compound stains well with the intravenous
or close-arterial dose of the drug. Staining of cholinesterase when this
compound is used to protect the enzyme against OFP is expected at even
lower doses than used here (Koelle, 1951). There ia evidence from tneae
photographs that the amount of staining is greater here than it was in tne
control aections. The increase in twitch with both dos.s was greater
compared to that tlbtained with all other facilitators. Thls facilitation
was such that the injection of OFP did not increase it further.

There

were fasciculations and other signs similar to those seen in the course
of organophosphate poisoning before the DFP was given; however, none
of the animals died after DFF, so the compound seemed capable of
protecting against the lethal affects of DFP.
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FIGURE 7
A MBENONIUM IN VIVO_

250 ug.

5

i. v.

ug. c. a.

II.
A.

~

VITRO

Neostigmine
The results..!!!!!!!:£>with this compound are shown in fig. 8. These

pictures mimic those of the!!!. '!.!!2 results with this compound. There
appears to be some diffusion that was not apparent!!!. !1.:!:2. However.
the low concentration (3. 32 X 10

-8

M)

of neostigmine shows no staining

as before and, likewise, the higher concentration (1. 65 X 10'" 6M)
shows staining.
B. Edrophonium
Figure 9 show the results with edrophonium. These are the same
as those found !!!. ~ showing no staining at either the low (5. 52 X 10
or high (2.76 X 1O-6 M) concentration.

-8

M)

Unless concentrations of 1 X lO-3M

edrophonium are used with this technique the end-plates are not expected
to stain (Christoff, Anderson, S1otwiner, and Song. 1966).

c.

Methoxyambenonium
The results with methoxyambenonium are shown 1n fig. 10. These

were not the same as those seen!!!.!!!9.

With the higher concentration

(9.25 X 10- 7M) we see the "hairlike" pa.al staining which we assume
is partial protection of the enzyme by the compound.

Here, however.

this type of staining occurred also at the lower concentration (1.85 X lO-8M)
The amount of staining seen in the sections does not appear to differ.

F IGURE 8
NEOSTIGMINE IN VITRO

1.6 5 X l O- 8 M

47

FIGURE 9
EDROPHONIUM IN VITRO

F IGURE 10
METHOXYAMBE NONIUM IN VITRO

81\4
.l.
1. 85 X 10-
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D.

Ambenoniu$

With this co.mpound there was staining: at both the low (1. 83 X lO-8 M )

and high (9. 15 X 10- 7M) concentrations. Figure 11 indicates a more intense
stain than that of the control sections so that these results are in agreement with those obtained .....................
in vivo. The in vivo and ...........................
in vitro results with
--~

this compound show a much greater amount of stain occurring with it
than with the methoxy derivative. This would agree with others who
have found it to be 100 times .s potent an inhibitor of cholinesterase
as methoxyambenonium (Koene, 1957; Blaber, 1960).

FIGURE 11
AMBENONIUM IN VITRO

---

-

1.,83
X lO-8 M
,
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DISCUSSION

The results presented in this thesis (fig. 12) have demonstrated a
lack of correlation between the abUities of certain facllitatory drugs to
potentiate the maximal indirect twitch and to inhibit the acetylcholinesterase
present in skeletal muscle. These results therefore support the conclusions
of others (Randall, 1950; Wescoe and Riker, 1951; Riker, 1953; Karczmar,

1957; Blaber, 1980; Blaber and Bowman, 1982; Blaber, 1983 a, b) that some
action or actions, in addition to cholinesterase inhibition, play an important
part in the ability of these drugs to potentiate the responses of the musele

to nerve stimulation.
In the present experiments ambenontum proved to be the most potent

anticholinesterase of the drugs used. FollOWing the injection of this compound the amount of choJJ.nesterase staining, the increase in the size of
muscle twitch, and the fasclculationa Observed in the ammals all pOinted to
cholinesterase inhibition. It also proved capable of protecting the animal
against the lethal dose of DFP even though it produced signs similar to
organophosphate poisoning. This compound certainl7 may cause factlltatlon
at the neuromuscular junction through an anticholinesterase action.
Edrophonium was not inhibiting cholinesterase at the dose levels used
in the experiments, or it was rapidly disassociated in the presence of DFP
in a similar way to that described by Wilson (1965) in the presence of

acetylcholine. It has been shown recently that concentrations of the order
of 1 X 10· 3 M of edrophonium are necessary with this technique before

FIGURE 12
SUMMARY OF RESULTS

ACHE

INHIBITION

INVITRO

INVIVO
DRUG
250 IJg

I.v.

5 IJg

c.o.

Low

Conc.

High Conc.

NEOSTIGMINE

+

-

-

+

EDROPHONIUM

-

-

-

-

AMBENONIUM

+

+

+

+

METHOXYAMBENONIUM

+-

+-

+-

-

staining of cholinesterue wUl appear (Christoff, Anderson, Slotwlner and

Song. 1966). In microelectrode studies anticholinesterase effects are seen
with edrophomwn, bUt at concentrations higher than the lower dose used in
the present experirnents which caused an increase in fllusc1e twitch (ChriSt.

personal comrr.un1cation). The lack of faaclculations or other antich.olines'"

terase signa following the achninistratioD of edrophon1urn and before the DFP
was liven coupled with the absence of hiBtochemical staining would substant1ate a theory that the increase in ".. :.usele twitch ..'\I ith edrophonium may be
caused via a mechanism other than cholinesterase inhibition.

In the present studt.s the low concentration of n .. etboxyambenomum

produced some ?rotectionja vitrs! but ienerally not 19. ~ The high con·
centration also appeared to produce only partial protection.

This may indJ....

cat. that the as.ociat1on ot the drug vvitb the cholinesterase molecule is slow,
and at the low concentrationJ,Q vivo there was insufficient t.tm.. lor any

appreciable inhibition. The facU1taUon Ot Alluscle twitch was immediate.
and the anticurare effect of the cOlnpound has also been reported to oe rapid
(Blaber, 19(0).

The total absence of atG" observable anticholinesterase

signs in the animal preceding the injection of DFP coupled with the anUcurare
potenc)" of this compound would certainly impl.;y a n:..echanisrrJ.

ot action for thi

compound other than choUnesterase inhibition. The alight staining of the

enzym.e in the present experiments proved to be inadequate to cause any
signs of cholinesterase inhibition that we would expect and was unable to

~:

6

protect the animal from the DFF. This may mean that the eholinesterase
molecule is a usecondary" or • tertiary receptorf! for this

COIn pound.

Tm t

is, only at higher dose levels than used in the present experinJientsl.vould the

anticholinesterase action of this compound possibly contribute ed.f,rnificantly

to its effects. Compounds \vhich have an effect at the l'leUrOXlluscular junction would be expected to fit rnany r'eceptors in that area. but each

rece~tor's

a.ttraction to a particular compound is different. The fact that r:netnoxyambenoniwn is very aIm\' to dissociate from cholinesterase (Koelle. 1957) may
a.ccount for the compound possessing little anticholinesterase)otency and
yet still remain on therLolecule throughout the DFP treatrnent and staining
procedure.
In low doses neostifilnine gave gross and htstocherrJ.ical signs simUar

to those obtained with edrophonium, 1. e., an increase in muscle twitch
without gross anticholinesterase signs in the animal or any histochemical
staining of cholinesterase, and the animal dying after Dfi-tP treatnlent.

i'lli

an mcrease in dose. neostigmine gave results liltethose obtained wlt.'l
arnbenoniunl.

There were fasciculations in the anirrl.al, a large in.crease in

muscle twitch, protection against the lethal effects of DFP, and hlstocherrl.ical staining of choUnesterase. It ',I) auld therefore seem that neostigrl1ine in
lower doses exerts its action on a receptor other than tne cholinesterue
rnolecule. At hiiher dose levels cholinesterase inhibition will undoubtedly
add to the action, but to what extent this is important in the facUitation ol

neuromuscular transmission is debatable.

One should only asaurne that it ls

able to inhibit cholinesterase at hiJher dose levels V'ilich ,may not ada to its

action.
One cannot quantitate the

s~

in

tl:u.~

In.uscle sections.

There is

Uttle infonnation in the litera.ture as to now ll.iuch cholil18sterase there has

to be present to stain. One can cOlupare 61"ossly the a.znount of staining
between muscle sections though. and there is no doubt in the present studies
that

n.Htthoqan"4b~UlouiUlll

treated j,'lj,uscle wa.s intermediate in stain1n6 belween

edrophonium and ambenoniw.l"4.
The efficacy of the ;llethod used in

~Jronj,ot1n6

in::.r.uediate precipitat1Gn

is, of course. dependent upon the adequate penetra.tion of both copper thiocholine and copper

~cinate

from the surrounding L:'lediW:JJ. to the sites oi the

e1lZTme in the tissues. The intensity of the specific stain at any site is
dependent upon

I:rla.ny

1actors. foremost

OfA-J.lic.n

are l>robably the concentra-

tion of the enzy.u.l.e and its reaction velocity or turnover number.

The

loca.Uzation iJf specific cholinesterase is iavored in the present technique
by a substrate concentration (5 X 10- 3 1:•.1) in the optirnal range for the

enzyme (Augustinsson. 1948). However. nonspecific esterases can also
~drolyr;e t..~e

substrate at this concentration. although at a

n1l6:

h slower

rate. In any histochemical procedure the question arises as to \vhether or
not the area where a :)recipUate is seen repreaents the actual site of
enzymatic action. The alternative interpretation is that dUfusion of the

initial product of bydrolysis or of the subsequent reaction product huL

~J

occurred. foUowed by a precipitation at an adjacent site. V( 1th the presen1
method the possibility of diffusion prior to precipitation was m1n1mized by
the addition of concentrated sodium sullate and a pH of 8. 1 (Koelle, 1951).
Since the results of the present experiments do not agree with the
classical anticholinesterase acUon of the compounds u•• d, an alternate
theory 18 needed to explain their eftects.
An action of acetylcholine at the autonomic ganglia, which may also
operate at the neuromuscular junction, has been suagMted by VoUe and
Koelle (1981) to be part of normalsyuaptic transmission. According to
their hypothesis. the pre- sJD&PUe nerve impulse causes the release of a
small amount of acetylcholine which then acts on the pre-synaptic nerve
endings to cause a greater release of the sarne transmitter whieb is then
aultlei.t to depolarize the post.. synaptic receptor.

The,. have also pro-

posed that an important function of ganglionic acetylcholinesterase may be

protection of the preganglionic term1Dations from depolarization and
antidromic t1r1ng in response to acetylcholine liberated by themselves and
adjaceJlt terminations. V/bether or not thia happens at the neuromuscular
juneUon has not been shown. Hubbard, Schmidt and Yokota, (1965), have
provided direct evidence for a depolarizing acUon of acetylcholine on nerve
terminala. It appears that the physiological action of acetylcbo!1ne may
provide a negative feedback on further acetylcholine release.

However.

Koelle (personal communication) is d.lcribina eventa that occur duritll one
. .
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action potential, where .. s Hubbard. Schmidt aDd Yokota are dbcu •• t.q the
effect. of .ucce ••ive action potentiab on each other.

Thia provide. another

cholinoceptlve lite·lor drul action at the neuromuscular junction.

A

mechartism for neuromuscular facilitation usinl anticholln••tera •• s would
be inhibition of choline.tera •• aUowhll acetylcholine to work at the presynaptic lite (1;ccle., Katz, Kufner, 194,,).

The result. of the pre.ent

experiment. indicate that ambenonium could work via this mecbanbm.

The

other compounds did not inhibit cholin••tera ••• and U they facilitate tran ....
mis.ioll via a prellynapticdte it InuIt b. thro"lh a db'ect action at the
receptor alte.
Karczmar. in con.ielerinl the ..CUOD. of certalD antichoUn •• teraae
inhibitor. at the neuromyal junction. found that the mono-and bi8-quaternary
inhibitors exhibit other action. which are not dependent on acetylcholine.tera •• inhibition.

There is incomplete correlation between acetylcholine.tera.e

inhibition, acetylcholine twitch. curare antagODism, aad mUlcle twitch
poteaUation (Karczmar, 1957). An intere.tial pheaomeaon 1n lh. fro, is
au,mllDtation without proloD,ation of the end plate potealial or acetylcholine
~epolarization

(Karczmar. Kim, Koketlllu, 1961). The.e workers cODclude

~hat

th•• e compound. .ensiU•• the end plate. .ince they lacUitate depolarba-

~ion

of the endplate without havill, a depolarbinl action 01 their own.

Neostigmine and edrophonium po.s ••• a direct depolarisinl action
~t

the motor enciplate but thie action has been shoWll to be too weak to

contribute to the facilitating action of these drugs on neuromuscular transmission (Hobbiger, 1952; Smith, Cohen, PeUkan and Unna. 1952; Nastuk and
Alexander" 1954).
Many experiments in which the eftecta of thue drugs were tested on
muscle and motor nerve action potentials led to the conclusion that they
possess an action on the n10tor nerve endings. Twenty-six years ago it
was shown that antidromic nerve activity occurred from the ventral roots
of cats during the muscular contraction provoked by the intra-arterial
~ection

of acetylcholine.

It was suggested as a result of these experiments

that neostigmine inh1bited acetylcholinesterase and allowed acetylcholine to
work on the nerve terminal (Masland and \Vigton. 1940). However, it is
clear from the calculations of Ogston (1955), that even it not destroyed by
choUnesterase. this acetylcholine would rapidly d1tfule away from the
junctional region.

The year followlng Maslarui's and

v~' 19ton'lI

work, Feng

and L1 (1941) suggested that anticholinesterases worked directly on the nerve
terminal. Other workers concluded that repetitive firing of the muscle
caused the backfiring on the nerve (Eccle., Katz and Kutner, 1942). This
latter concept was accepted until Riker, Roberta, Standaert and Fujimori
(1957), using a compound which blocked muscle potentials, were st1ll able

ta record antidromic phenomenon on the nerve. It has been shown that the
whole of the swnmed muscle acUon currents are required to produce a back
response in responsive nerve ttbers (lloyd, 1942; Brown and Matthews, 19(0)

This is the ephaptic back res?onse initiated in SatHe n.otor fibers by the
muscle action current. These workers have also demonstrated that when
the muscle i8 submaximally stimulated the ephaptic potential disappears.
Anticholinesterase compounds have been observed to cause backfiring in
ventral roots in the presence of a submaxinlally stimulated muscle (\\ emer,
1960). Blaber and Bow-man (1963b) have shown that the duration of the
repetitive discharges produced by close-arterially injected edrophonium and
neostigmine was approximately 50 rnilliseconds following each main nerve
spike, and this corresponds closely with the duration of the negative afterpotential of the nerve terminal as recorded by Hubbard and Schmidt (1961).
Ambenonium was observed to cause antidromic tiring for 300 mUlaeconds
and methoxyambenonium was the only drug studied which. by itself. was
unable to elicit antidromic activity in motor aKons (Blaber and Bowman,
1963b). From the results of the present experiments it seems that the
prolonged duration of repetitive firing produced by ambenoniUIrl in Blabert s
and Bowman's experiments may well have been due to preserved acetylcholinEio
This is not true of edrophonium and neostigmine which could act via the
pre-synaptic mechaDiam, nor of methoxyambenonium which appears to act
via a mechanism w ilich does not involve preservation of transmitter or the
pre-synaptic mechanism.
The results obtained in the present study support the view that
facUitatory drugs act at more than one site at the neuromuscular junction.
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All the drugs used in this work have been shown to inhibit cholinesterase

to some extent (Blaber, 1963), all appear to have some action at the nerve
terminal (Blaber, et a1. 1963 a, b) and some ha.ve been shown to possess
either a curare .. Uke, depolarizing, or sensitizing action on the end-plate
(Karczmar, 1957; Karczmar, et ai, 1961). This suggests that the receptor
characteristics at all three sites are similar and it may be impossible to
produce a drug which selectively combines at one site only.

To produce a.ny

one of these actions, different molecular characteristics are required which
frequently, but not necessarily, occur in association with each other.

Viewee

in this way, we are merely measuring a degree of overlap of classes of

agents endowed with inde?fmdently variable actions.

Interaction betw'een

different receptor sites must always occur, particularly with higher
concentrations produced by intravenous administration, and this probably
explains why their effects on transmission cannot be correlated with any
single action of the drugs.

Our results show that with close arterial

injections facilitation of r.1uscle twitch results, without inhibition of cholinesterase, which differed from intravenous administration of the compounds.
Ambenonium was the only drug used which inhibited cholinesterase to a
large eldent dudng c. a. injection, and it is therefore possible that the action
of ambenonium is more dependent upon preserved acetylcholine at effector
cells than at other sites w here the drug has actions.
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